• Marvel Biosciences expanded its previously announced private placement to investors resident in Quebec.
• An amended and restated offering document dated Aug. 19, 2026 was filed for the offering.
• The securities were not registered under the U.S. Securities Act of 1933, restricting offers or sales in the U.S.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marvel Biosciences Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608191306NEWSFILECNPR____20260819_310470_1) on August 19, 2026, and is solely responsible for the information contained therein.